DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Heart Failure 111

DAIC

APRIL 1, 2024

“We are witnessing a paradigm shift in how valvular heart diseases are diagnosed and treated,” said Partho Sengupta , Henry Rutgers Professor of Cardiology and chief of the Division of Cardiovascular Disease and Hypertension at Rutgers Robert Wood Johnson Medical School. Is There Medication for Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

DAIC

FEBRUARY 1, 2024

million, or 47% of adults are estimated to have hypertension.** Addressing strategies for companies in this industry, the market analysts offer two keys to driving future growth, writing: “Focusing on the development of innovative lipid-lowering drugs is an effective strategy for success in the Atherosclerosis Drugs Market.

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Peripheral Arterial Disease Stroke 104

DAIC

JUNE 24, 2024

At Endotronix, we firmly believe that innovation can drive patient care excellence in the home and ultimately change outcomes for patients with heart failure, one of the largest cost categories in healthcare. Secure messaging on a tablet between the clinical team, patient, and caregiver to support remote care.

Heart Failure 109

Heart Failure Reimbursement Heart Transplant Pulmonary 109

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105

Journal of the American Heart Association

JANUARY 16, 2024

BackgroundSmartphone applications and wearable devices are promising mobile health interventions for hypertension self‐management. Journal of the American Heart Association, Volume 13, Issue 2 , January 16, 2024. However, most mobile health interventions fail to use contextual data, potentially diminishing their impact.

Blood Pressure 67

Blood Pressure Diet Innovation Hypertension 67

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Heart Failure 52

DAIC

MAY 21, 2024

The study is the largest and most robust of its kind to date, examining 102,475 Hello Heart users with high BP (hypertension) between January 2018 and December 2022. Founded in 2013, Hello Heart is a digital leader in preventive heart health and a member of the American Heart Association’s Innovators’ Network. of their body weight.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

Cardiometabolic Health Congress

AUGUST 8, 2024

We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization.

Education 59

Education Kidney Disease Cardiovascular Disease Diabetes 59

DAIC

DECEMBER 19, 2023

This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression.

Heart Failure 52

Heart Failure Heart Disease Innovation Quality of Life 52

Cardiometabolic Health Congress

AUGUST 2, 2024

This innovative approach integrates personal data from multiple biological layers to design bespoke dietary plans, transcending the limitations of one-size-fits-all recommendations. This is particularly beneficial in managing conditions like hypertension, where precise control of dietary sodium intake is crucial.

Diet 59

Diet Technology Coronary Artery Disease Quality of Life 59

Dr. S. Venkatesan MD

APRIL 18, 2024

May be, it will come soon in the innovative lanes of cardiology. This is to create a small regulatory orifice in the IAS ( A complicated term for a small ASD ) to decompress the LA and reduce pulmonary congestive symptoms. Curious minds might ask, can’t we decompress LV it self by creating a small VSD.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Pulmonary Congenital Heart Disease VSD 40

DAIC

FEBRUARY 16, 2024

By expanding our HeartRisk platform, we're not just innovating within traditional healthcare sectors but breaking new ground in diverse markets. The incarcerated population exhibits higher rates of cardiovascular risk factors, such as smoking and hypertension, compared to the general population.

Chronic Disease 91

Chronic Disease Heart Attack Heart attacks Heart Disease 91

Wellnest

DECEMBER 18, 2023

These groundbreaking developments offer a paradigm shift in the management of resistant hypertension, especially when it is extremely difficult to achieve blood pressure control through conventional means, such as lifestyle modifications and various drug therapies. But what is resistant hypertension, and why does it require renal denervation?

Hypertension 52

Hypertension Blood Pressure Reimbursement Ablation 52

Vector Remote

APRIL 14, 2023

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.

Pacemaker 52

Pacemaker Technology COVID-19 Blood Pressure 52

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) Effect of Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients with Elevated Risk For Major Adverse Cardiovascular Events.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

The Beat Blog

MAY 2, 2023

4 Conditions such as Ischemic Heart Disease, Atrial Fibrillation, Hypertensive Heart Disease, and Ischemic Stroke make up almost 75% of the deaths due to cardiovascular disease. 5 These conditions, if detected and addressed early and appropriately, can be treated and prevented. Doing so also helps address socio-economic barriers.

Atrial Fibrillation 52

Atrial Fibrillation Cardiovascular Disease Technology Hospital 52

Dr. Smith's ECG Blog

DECEMBER 27, 2018

Cardiologs founder, Yann Flereau, was named by MIT as the European Innovator of the Year. But in a patient without any such symptoms — marked LVH in a patient with severe longstanding hypertension may sometimes produce very similar ST-T wave changes as are seen in Figure-1. What an honor. What do you think?

Chest Pain 52

Chest Pain Hypertension STEMI Heart Disease 52

DAIC

APRIL 6, 2024

Natalie Bello, MD, MPH , director of Hypertension Research, will present “What’s Sex Got to Do With It? Addressing Hypertension in Women,” Monday, April 8, 12:45-1 p.m. Gupta is one of 28 structural heart cardiologists and surgeons selected for CTR’s new Project REACH.

Research 105

Research Cardiac Arrest Electrophysiology Chest Pain 105

Dr. S. Venkatesan MD

JANUARY 25, 2024

For the busy cardiologists, this will a be refreshing reminder, that there are other important organs and specialties do exist in medicine , with equal breakthroughs and Innovations. Baxdrostat, an Aldosterone synthase antagonist for treatment-resistant Hypertension, appears promising (BrigHTN).

Research 52

Research Article Document Public Health 52

DAIC

JUNE 27, 2024

Anumana has received FDA Breakthrough Device Designation for four of its algorithms: low ejection fraction, pulmonary hypertension , cardiac amyloidosis, and hyperkalemia. The companies will also work together to validate the clinical utility of the integrated solution and seek regulatory clearance to bring this technology to market.

Technology 105

Technology Heart Rhythm Heart Failure Innovation 105

DAIC

FEBRUARY 12, 2024

CVRx is a commercial-stage medical device company focused on the developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. It has also received the CE Mark for heart failure and resistant hypertension in the European Economic Area.

Heart Failure 104

Heart Failure Hospital Quality of Life Heart Attack 104

DAIC

FEBRUARY 12, 2024

CVRx is a commercial-stage medical device company focused on the developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. It has also received the CE Mark for heart failure and resistant hypertension in the European Economic Area.

Heart Failure 52

Heart Failure Hospital Quality of Life Heart Attack 52